Propanc Biopharma PPCB
NASDAQ PPCB
$1.08 -0.02 (-1.82%)
At close: Aug 21, 2026 · 4:00 PM EDT

Propanc Biopharma (PPCB) Property, Plant & Equipment (Net) (2011 - 2025)

Propanc Biopharma (PPCB) Property, Plant & Equipment (Net) (2011 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Propanc Biopharma 587,855.41 587,855.41 - 4,397.00

Historic Data

Download Data
DateValue
Dec 31, 2025 4,397.00
Dec 31, 2025 4,397.00
Sep 30, 2025 2,364.00
Sep 30, 2025 2,364.00
Dec 31, 2023 50.00
Dec 31, 2023 50.00
Sep 30, 2023 160.00
Sep 30, 2023 160.00
Jun 30, 2023 302.00
Jun 30, 2023 302.00
Mar 31, 2023 634.00
Mar 31, 2023 634.00
Dec 31, 2022 1,083.00
Dec 31, 2022 1,083.00
Sep 30, 2022 1,437.00
Sep 30, 2022 1,437.00
Jun 30, 2022 2,023.00
Jun 30, 2022 2,023.00
Mar 31, 2022 2,706.00
Mar 31, 2022 2,706.00